Howard Collins Miller Iii

age:

68 years

appointments:

25 active

0 prior

primary industry:

Other professional, scientific and technical activities

about Howard

Since 2023, Mr Miller Iii has been a director of 25 companies, the current directorship have a combined turnover of approximately £230.8m.

Combined Valuation

£4.6b

Combined Turnover

£230.8m

active directorships over time

company
turnover
valuation
start
end
status
role
alligent biopharm consulting (europe) limited£5.9m£1.2bSep 2023-OpenDirector
envision pharma midco limited-£784.3mSep 2023-OpenDirector
envision pharma finco limited-£718.2mSep 2023-OpenDirector
envision pharma bidco limited-£500.4mSep 2023-OpenDirector
evidence topco limited£203.2m£490.2mSep 2023-OpenDirector
evidence midco limited-£395.9mSep 2023-OpenDirector
evidence finco limited-£330.4mSep 2023-OpenDirector
engage scientific solutions limited£751k£34.3mSep 2023-OpenDirector
90ten ltd.£10.5m£26.4mSep 2023-OpenDirector
excel scientific solutions limited-£24.1mSep 2023-OpenDirector
elevate scientific solutions limited£392.3k£14.9mSep 2023-OpenDirector
evidence scientific solutions limited£711.2k£11.5mSep 2023-OpenDirector
curo consulting limited£404.2k£7.3mSep 2023-OpenDirector
touch creative design limited-£5.1mSep 2023-OpenDirector
envision pharma limited£7.3m£3.7mSep 2023-OpenDirector
okra technologies limited£613.9k£2.7mSep 2023-OpenDirector
90ten group limited-£2.2mSep 2023-OpenDirector
20senses limited£885k£1.4mSep 2023-OpenDirector
eloquent scientific solutions limited-£1.8Sep 2023-OpenDirector
envision pharma trustee limited-£1.7Sep 2023-OpenDirector
pennside partners uk limited--Sep 2023-OpenDirector
envision pharma holdco limited--Sep 2023-OpenDirector
okra holdings limited--Sep 2023-OpenDirector
envision market access solutions limited--Sep 2023-OpenDirector
envision pharma group limited--Sep 2023-OpenDirector